| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | RG-108 | CTRPv2 | pan-cancer | AAC | -0.045 | 0.2 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | -0.043 | 0.2 |
| mRNA | BRD-K09344309 | CTRPv2 | pan-cancer | AAC | -0.096 | 0.2 |
| mRNA | JQ-1:UNC0638 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.042 | 0.2 |
| mRNA | UNC0321 | CTRPv2 | pan-cancer | AAC | -0.045 | 0.2 |
| mRNA | Rapamycin | CTRPv2 | pan-cancer | AAC | -0.042 | 0.2 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | 0.069 | 0.2 |
| mRNA | ML210 | CTRPv2 | pan-cancer | AAC | -0.04 | 0.2 |
| mRNA | GDC-0941 | CTRPv2 | pan-cancer | AAC | -0.043 | 0.2 |
| mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | -0.042 | 0.2 |